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Abstract. 
 
Cell adhesion molecules of the Ig superfam-
ily are implicated in a wide variety of biological pro-
cesses, including cell migration, axon guidance and fas-
ciculation, and growth control and tumorigenesis. 
Expression of these proteins can be highly dynamic and 
cell type specific, but little is known of the signals that 
regulate such specificity. Reported here is the molecu-
lar cloning and characterization of rat CDO, a novel 
cell surface glycoprotein of the Ig superfamily that con-
tains five Ig-like repeats, followed by three fibronectin 
type III–like repeats in its extracellular region, and a 
256-amino acid intracellular region that does not re-
semble other known proteins. In rat embryo fibro-
 
blasts, 
 
cdo
 
 mRNA expression is maximal in confluent, 
quiescent cells. It is rapidly and transiently down-regu-
lated by serum stimulation of such cells, and is constitu-
tively down-regulated in oncogene-transformed deriva-
tives of these cells. CDO protein levels are also 
dramatically regulated by cell–substratum adhesion, via 
a mechanism that is independent of 
 
cdo
 
 mRNA expres-
sion. The amount of CDO produced at the surface of a 
cell may therefore be governed by a complex balance of 
signals, including mitogenic stimuli that regulate 
 
cdo
 
 
mRNA levels, and substratum-derived signals that reg-
ulate CDO protein production. 
 
cdo
 
 mRNA is ex-
pressed at low levels in most adult rat tissues. A closely 
related human gene maps to chromosome 11q23–24, a 
region that displays frequent loss of heterozygosity in 
human lung, breast, and ovarian tumors. Taken to-
gether, these data suggest that loss of CDO function 
could play a role in oncogenesis.
 
C
 
ell
 
 adhesion molecules (CAMs)
 
1
 
 of the Ig super-
family (IgSF) are implicated in cell–cell interactions
that mediate, in part, a wide variety of develop-
mental, physiological, and pathological processes (for re-
views see Edelman and Crossin, 1991; Hynes and Lander,
1992; Brummendorf and Rathjen, 1995; Cunningham,
1995). In general, CAMs of the IgSF mediate Ca
 
2
 
1
 
-inde-
pendent, homo- and heterophilic cell–cell adhesion. These
molecules typically possess an extracellular region that
consists of several Ig-like domains followed, in many
cases, by a number of fibronectin type III (FNIII)–like do-
mains. Members of the IgSF that contain both Ig-like and
FNIII-like repeats (e.g., neural cell adhesion molecule
(N-CAM), L1, F11/contactin, etc.) have been mainly im-
plicated in developmental processes in the nervous system,
including cell migration, neurite extension, and axon guid-
ance and fasciculation (Hynes and Lander, 1992; Tessier-
Lavigne and Goodman, 1996).
Cell–cell recognition also plays an important role in the
proliferative capacity of cells both inside and outside the
nervous system, and Ig/FNIII family members may be in-
volved in this phenomenon as well. For example, cell sur-
face N-CAM mediates contact inhibition of growth of a
mouse fibroblast cell line (Aoki et al., 1991), and addition
of soluble N-CAM to primary cultures of rat astrocytes
specifically inhibits their proliferation (Sporns et al., 1995).
Consistent with a role for CAMs in controlling cell pro-
liferation, a large body of evidence suggests that alter-
ations in adhesion-mediated cell regulation may play a
role in induction and/or maintenance of the neoplastic
phenotype (for review see Hedrick et al., 1993). It has
been known since the 1940s that cancer cells display al-
tered adhesiveness when compared to their normal coun-
terparts (Coman, 1944). Moreover, malignant tumors ex-
hibit a loss of appropriate tissue architecture, altered cell
shape, cell crowding, and invasiveness. Tumor cell lines, or
cells transformed in vitro, show a loss of contact inhibition
of growth and proliferate in an anchorage-independent
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fashion. Although the molecular bases of these pheno-
types are still poorly understood, they may arise, in part,
because of loss of expression or mutational inactivation of
genes that encode CAMs (Hedrick et al., 1993; Berx et al.,
1996).
A candidate tumor suppressor gene, 
 
DCC
 
, encodes a
member of the Ig/FNIII family containing four Ig-like re-
peats, and six FNIII-like repeats in its extracellular region
(Fearon et al., 1990; Hedrick et al., 1994; for reviews see
Fearon and Pierceall, 1995; Fearon, 1996). 
 
DCC
 
 was iso-
lated by positional cloning in a region of chromosome 18q
that commonly displays loss of heterozygosity (LOH) in
colorectal cancers. 
 
DCC
 
 was included in the region of al-
lelic loss in 
 
.
 
90% of colorectal cancers that exhibited
LOH of 18q. Furthermore, loss of DCC protein expression
in colorectal tumors is a negative prognostic marker of
survival rate in patients with stage II and stage III disease
(Shibata et al., 1996). Additional studies of 
 
DCC
 
 expres-
sion and allelic loss indicated that this gene may also be in-
volved in many additional types of cancer and may play a
role in cell differentiation (Fearon, 1996). DCC was also
recently shown to function as an evolutionarily conserved
receptor or component of a receptor for netrin-1, a se-
creted and membrane-associated protein that acts as a
guidance cue for migrating axons in the developing ner-
vous system (Chan et al., 1996; Keino-Masu et al., 1996;
Kolodziej et al., 1996). These data raise the possibility that
loss of DCC function could alter the motility of cancer
cells.
An additional IgSF member implicated in carcinogene-
sis is cell–cell adhesion molecule (C-CAM)/biliary glyco-
protein, which contains four Ig-like domains in its extra-
cellular region. Expression of the 
 
C-CAM
 
/
 
Bgp-1
 
 gene was
down-regulated in colorectal and prostate malignancies
(Kleinerman et al., 1995; Neumaier et al., 1993), and ec-
topic restoration of its expression suppressed tumorigenic-
ity of cell lines derived from such tumors (Hsieh et al.,
1995; Kunath et al., 1995).
It is clear from the studies cited above that CAMs of the
IgSF play a role in coordinating normal cellular architec-
ture, motility, and growth control, and that loss of function
of such molecules may play an important role in multi-
stage carcinogenesis. We have previously developed and
characterized a panel of somatic cell mutant lines derived
from Rat 6 embryo fibroblasts that are specifically resis-
tant to the induction of anchorage-independent growth by
various oncogenes (Krauss et al., 1992; Feinleib and Krauss,
1996; Kang and Krauss, 1996). Because the oncogene-
resistant phenotype of these cells was dominant in somatic
cell hybridizations, we sought to isolate genes whose ex-
pression is up-regulated in the mutant cell lines relative to
a transformation-sensitive control cell line. Reported here
is the molecular cloning and characterization of a rat gene
designated 
 
cdo
 
 (CAM-related/down-regulated by onco-
genes), which encodes a novel transmembrane member of
the Ig/FNIII family. In rat fibroblasts, 
 
cdo
 
 expression is
maximal in confluent, quiescent cells. 
 
cdo
 
 mRNA and pro-
tein levels are strongly, but transiently, reduced when such
cells are stimulated to reenter the cell cycle and are consti-
tutively down-regulated in oncogene-transformed deriva-
tives of these cells. Furthermore, CDO protein levels are
strikingly regulated by cell–substratum adhesion, with a
 
mechanism that is independent of 
 
cdo
 
 mRNA expression.
A closely related human gene maps to chromosome
11q23–24, a region that displays LOH in human lung, breast,
and ovarian tumors. Taken together, these data suggest
that loss of CDO function might play a role in oncogenesis.
 
Materials and Methods
 
Cell Culture
 
All Rat 6–derived cell lines were routinely maintained in DME plus 10%
bovine calf serum, as previously described (Krauss et al., 1992). NIH 3T3
and NIH 3T3/
 
ras
 
 cells were cultured in DME plus 5% FBS. Soft agar as-
says and preparative methylcellulose cultures were performed as previ-
ously described (Kang and Krauss, 1996). Cells were harvested from pre-
parative methylcellulose cultures 48 h after inoculation into the semisolid
medium, and were 
 
.
 
98% viable as assessed by trypan blue dye exclusion
and replating assays (Kang and Krauss, 1996). For serum stimulation ex-
periments, confluent cultures of Rat 6 cells were washed twice with PBS,
and fed with DME plus 0.1% calf serum. After 48 h, the cultures were
refed with DME plus 20% calf serum and harvested for analysis at various
time points thereafter.
 
RNA Isolation, Library Construction, and Screening
 
RNA used for cDNA library construction was prepared by the guanidine
thiocyanate/cesium chloride centrifugation method (Chirgwin et al., 1979),
and the poly(A)
 
1
 
 fraction was isolated by oligo(dT)-cellulose chromatog-
raphy (Aviv and Leder, 1972). RNA used for Northern blot analyses was
isolated either as described above or with the TRIzol reagent (GIBCO
BRL, Gaithersburg, MD), which was used according to the manufac-
turer’s instructions.
An oligo(dT)-primed cDNA library was constructed in 
 
l
 
ZAPII (Strat-
agene, La Jolla, CA) with mRNA isolated from the transformation-resis-
tant, mutant cell line, R-1a (Krauss et al., 1992). The library was con-
structed with the SuperScript Choice system kit from GIBCO BRL, and
was screened by differential hybridization (Johnson et al., 1987) with
 
32
 
P-labeled cDNA prepared from R-1a and control, transformation-sensitive
PKC3-F4 cells. One clone that exhibited a greater signal with R-1a–derived
cDNA, relative to PKC3-F4–derived cDNA, represented a partial cDNA
for 
 
cdo.
 
 Clones representing a nearly full-length cDNA were isolated
from a random-primed 
 
l
 
ZAPII library constructed with mRNA from Rat
6 cells. A human cDNA that is closely related to rat 
 
cdo
 
 was isolated by
screening human fetal lung and fetal brain cDNA libraries (obtained from
A. Chan and S. Aaronson, Mount Sinai School of Medicine; and Clontech,
Palo Alto, CA, respectively) with the full length rat 
 
cdo
 
 cDNA.
 
DNA Sequencing and Computer Analysis
 
DNA sequencing was carried out by a combination of manual and auto-
mated methods. Manual sequencing was performed with a Sequenase 2.0
kit (United States Biochemical Corp., Cleveland, OH). Automated se-
quencing was performed at the Mount Sinai Molecular Biology Core Fa-
cility on an Applied Biosystems 373 computerized DNA sequencer (Fos-
ter City, CA) or at the Biotechnology Center at Utah State University
(Logan, UT). Searches of the DNA databases were performed with the
BLAST server service, and sequence analysis and alignments were carried
out with MacVector (International Biotechnologies, Inc., New Haven,
CT) and GCG software (Genetics Computer Group, Madison, WI).
 
RNA Analyses
 
Northern blot analyses were performed by fractionating total cellular or
poly(A)
 
1
 
 RNA through agarose/formaldehyde gels, blotting to nylon mem-
branes, and hybridizing with DNA probes as described by Krauss et al.
(1992).
For the study of 
 
cdo
 
 expression in adult rat tissues, PCR-based “exon-
connection” assays were carried out (Fearon et al., 1990). A portion of the
 
cdo
 
 gene was isolated from a rat genomic library (a gift of S. Salton,
Mount Sinai School of Medicine) and a partial exon/intron structure de-
duced over a 
 
z
 
15-kb region. Random primers and reverse transcriptase
were used to generate cDNA from total RNA derived from rat tissues.
PCR primers (5
 
9
 
-CACACAGTCAGAAGCGTTCCTC-3
 
9
 
 [sense], and 5
 
9
 
- 
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AGGATAAGAGGCTACCACTGGG-3
 
9
 
 [antisense]) directed against se-
quences from separate exons were then used to amplify a cDNA product
that linked these exons. PCR reactions were fractionated on agarose gels,
blotted to nylon membranes, and probed with a 
 
cdo
 
 cDNA probe. To ana-
lyze differential splicing of the fifth Ig repeat of 
 
cdo
 
 in Rat 6 cells, reverse
transcription–PCR was performed on total Rat 6 cell RNA with the fol-
lowing primers: 5
 
9
 
-GGAAGCAACTGGAGAAGG-3
 
9
 
 (sense) and 5
 
9
 
-
GTCTCGTTCATCGTTCTG-3
 
9
 
 (antisense). The products were analyzed
by agarose gel electrophoresis and ethidium bromide staining.
 
Flow Cytometry
 
Cells were stained with propidium iodide buffer (50 
 
m
 
g/ml propidium io-
dide, 0.1% sodium citrate, 0.1% Triton X-100) in the presence of 10 
 
m
 
g of
DNase-free RNase and analyzed by flow cytometry on a fluorescence-
activated cell sorter (FACS
 
®
 
can; Becton and Dickinson, Co., Mountain
View, CA). The data were analyzed by the CellFIT software program
(Becton and Dickinson, Co., Mountain View, CA).
 
Antibodies and Western Blot Analyses
 
A portion of the intracellular region of rat 
 
cdo
 
 (amino acids 1057–1241)
was ligated into pGEX-5X-1 (Pharmacia LKB Biotechnology Inc., Piscat-
away, NJ) to produce a glutathione-
 
S
 
-transferase fusion protein. Fusion
protein produced in 
 
Escherichia coli
 
 was purified by SDS-PAGE and elec-
troelution. Rabbit polyclonal antibodies to CDO protein were generated
with a proprietary immunization regimen referred to as PolyQuik
 
TM
 
(Zymed Laboratories Inc., South San Francisco, CA). Crude antisera
were used for Western blot analyses.
Immunoblot analyses were performed essentially as described in Kang
et al. (1996). Cells from monolayer or methylcellulose suspension cultures
were harvested in radioimmunoprecipitation assay (RIPA) buffer (10 mM
Tris-HCl, pH 7.2,150 mM NaCl/1% Triton X-100/1% sodium deoxycholate/
0.1% SDS/1 mM EGTA) containing 1 mM PMSF, 10 ng/ml leupeptin, 50 mM
NaF, and 1 mM sodium orthovanadate. Total proteins were then sepa-
rated by SDS-PAGE, transferred to nitrocellulose membranes (Amer-
sham Corp., Arlington Heights, IL), and probed with anti-CDO antiserum.
The blots were washed and reprobed with HRP-conjugated secondary an-
tibody and specific protein bands visualized with the ECL chemilumines-
cent detection system (Amersham Corp.) as described previously (Kang,
et al., 1996).
 
Surface Labeling and Tunicamycin Treatment
 
To surface biotinylate Rat 6–derived cultures, cells were detached in 0.04%
EDTA in PBS, washed with serum-free DME, and incubated on ice with
serum-free DME plus 50 
 
m
 
M sulfo-NHS-LC-biotin (Pierce Chemical Co.,
Rockford, IL) for 0.5 h. Cells were then washed again and lysed in RIPA
buffer, and CDO was immunoprecipitated. Western blotting was then
performed as described above, except that HRP-linked streptavidin was
used for detection. To assess N-glycosylation of CDO, Rat 6 cells were
treated with tunicamycin (5 
 
m
 
g/ml) for 48 h, lysed, and analyzed by West-
ern blotting.
 
Ectopic Expression of cdo
 
A complete rat 
 
cdo
 
 open-reading frame, including 95 bp of the 5
 
9
 
 untrans-
lated region and 633 bp of the 3
 
9
 
 untranslated region, was reconstructed
from overlapping bacteriophage inserts and ligated into the retroviral ex-
pression vector, pBabePuro (Morganstern and Land, 1990). Production of
recombinant retroviruses and infection of Rat 6–derived cell lines was per-
formed as previously described (Krauss et al., 1992). Infected cultures were
selected in medium that contained 5 
 
m
 
g puromycin per ml, and 
 
.
 
1,000 in-
dependent, drug-resistant colonies were pooled and analyzed as described
in Results.
 
Chromosomal Localization of Human cdo
 
A portion of the human 
 
cdo
 
 gene was PCR amplifed from human mono-
chromosomal somatic cell hybrids. The National Institute of General Medi-
cal Sciences human/rodent somatic cell hybrid mapping panel No. 2, ver-
sion 3 (Coriell Institute for Medical Research, Camden, NJ), was used for
chromosomes 1, 6–9, 11, 12, 14, 16, 17, 20, 22, X, and Y. The remaining
chromosomes were represented by monochromosomal hybrids: GM11686
(chr. 2); GM11713 (chr. 3); GM11687 (chr. 4); GM11714 (chr. 5);
GM11688 (chr. 10); GM11689 (chr. 13); GM11715 (chr. 15); GM12082
(chr. 18); GM10612 (chr. 19); and GM08854 (chr. 21) (Coriell Institute for
Medical Research). PCR amplifications were performed with the follow-
ing primers: 5
 
9
 
-CACAACAGGCTGGGAGCGA-3
 
9
 
 (sense), and 5
 
9
 
-
GGGGAAGAAAACATTTAAG-3
 
9
 
 (antisense). The identity of the chro-
mosome 11 monochromosomal hybrid was confirmed by PCR of the pre-
viously mapped locus catalase (11p13) (Theune et al., 1991). Human 
 
cdo
 
was further localized with a chromosome 11 regional mapping panel (Co-
riell Institute for Medical Research).
 
Results
 
Isolation, Sequence Analysis, and Tissue Distribution
of cdo
 
The R-1a and ER-1-2 mutant rat embryo fibroblast cell
lines are resistant to induction of anchorage-independent
growth by various oncogenes, and this property is domi-
nant in somatic cell hybridizations (Krauss et al., 1992).
Because this dominant resistance could have arisen by the
stable expression (or overexpression) of a transformation
suppressor gene, a cDNA library constructed from R-1a
cells was screened by differential hybridization to isolate
genes whose expression was enhanced in R-1a cells, rela-
tive to a transformation-sensitive control cell line, PKC3-
F4. One cDNA clone isolated in this screen, later named
 
cdo
 
, hybridized to an 
 
z
 
8.5-kb mRNA species that repro-
ducibly showed a mild (1.5–2-fold) up-regulation in both
R-1a and ER-1-2 cells, relative to the control PKC3-F4
cells (Fig. 1). Interestingly, 
 
cdo
 
 mRNA levels were dra-
matically down-regulated in PKC3-F4 cells that had been
infected with a v-H-
 
ras
 
–expressing retrovirus. This down-
regulation was incomplete in similarly infected cultures of
the 
 
ras
 
-resistant R-1a and ER-1-2 cell lines (Fig. 1).
Sequence analysis of overlapping cDNAs revealed 
 
cdo
 
to be a member of the Ig/FNIII repeat family. Fig. 2 
 
A
 
shows the predicted amino acid sequence of rat 
 
cdo
 
; also
shown is the amino acid sequence of a closely related hu-
man gene (see below). The rat 
 
cdo
 
 mRNA is predicted to
encode a 1,242–amino acid protein, comprised of a 24–
amino acid hydrophobic signal sequence followed by an ex-
tracellular region of five Ig V–like repeats (Vaughn and
Bjorkman, 1996) and three FNIII-like repeats, a 25-residue,
membrane-spanning region, and a putative intracellular
region of 256 amino acids. A hydropathy plot (not shown) is
consistent with a single membrane-spanning region, sug-
gesting that 
 
cdo
 
 encodes a transmembrane protein with a
structure similar to members of the N-CAM family. A sche-
matic representation of the predicted CDO structure is
shown in Fig. 2 
 
B.
 
 While there are no other IgSF members
with this numerical combination of Ig- and FNIII-like re-
peats in the current databases, individual Ig and FNIII re-
peats in 
 
cdo
 
 appeared to be most closely related to such
Figure 1. Northern blot anal-
ysis of cdo mRNA expres-
sion in the PKC3-F4, R-1a,
and ER-1-2 cell lines, plus or
minus infection with a v-H-
ras–expressing retrovirus. 1
and 2, expressing or not ex-
pressing v-H-ras, respec-
tively. The ethidium bromide–stained gel (displaying the 28S and
18S ribosomal RNA bands), is shown as a loading control. 
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repeats found in rat NB-2 and NB-3 (Ogawa et al., 1996),
members of the F11/contactin/F3 subfamily of CAMs (up
to 50% amino acid similarity; data not shown). Interest-
ingly, however, the putative intracellular region of 
 
cdo
 
showed no significant resemblance to any gene currently
in the standard databases. A proline-rich stretch in the
intracellular region that might serve as a potential SH3
domain binding site is indicated in Fig. 2 
 
A.
 
 10 potential
N-linked gycosylation sites present in the extracellular re-
gion are also indicated.
Sequencing of multiple, independent cDNAs revealed a
potential for alternative splicing of the fifth Ig repeat,
Figure 2. (A) Predicted
amino acid sequence of rat
and human CDO. Identical
residues are boxed. The five
Ig-like repeats are indicated
by the triangles, which corre-
spond to the two conserved
cysteines present in each do-
main (Williams and Barclay,
1988). The three FNIII-like
repeats are indicated by the
arrowheads, which corre-
spond to the conserved pro-
lines and leucines at the end
of each domain (Patthy,
1990). The putative signal se-
quence and transmembrane
regions are underlined in
bold. 10 asparagines in the
extracellular region that rep-
resent potential sites of
N-linked glycosylation are in
bold print. A proline-rich
stretch in the intracellular re-
gion is underscored with as-
terisks. These sequence data
are available from EMBL/
GenBank/DDBJ, under ac-
cession numbers AF004840
(rat), and AF004841 (hu-
man). (B) Schematic repre-
sentation of CDO structure,
which contains five Ig-like
repeats, three FNIII-like re-
peats, a transmembrane re-
gion (TM), and a 256–amino
acid intracellular region. Ig
repeat 5 (cross-hatched) is al-
ternatively spliced. 
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leading to removal of amino acids 400–516. Reverse tran-
scriptase–PCR analysis of total Rat 6 cell RNA with prim-
ers that flank this region produced a major product corre-
sponding to mRNA that encodes the fifth Ig domain, and a
minor product corresponding to mRNA that lacks this do-
main (data not shown). Consistent with the notion that
this is a minor splice variant in Rat 6 cells, only one major
form of 
 
cdo
 
 mRNA and protein was detected by Northern
and Western blot analyses of these cells (see below).
Expression of 
 
cdo
 
 in adult rat tissues was analyzed ini-
tially by Northern blotting of poly(A)
 
1
 
 RNA derived from
brain, liver, kidney, heart, large and small intestines, spleen,
thymus, lung, stomach, and skeletal muscle, but only a
very faint signal could be detected. This result was remi-
niscent of that observed for the related gene, 
 
DCC.
 
 We
chose, therefore, to use the “exon-connection” strategy
originally used by Fearon et al. (1990) to analyze 
 
DCC
 
 ex-
pression. A product of the predicted size was found in all
of the tissues examined except liver, kidney, and skeletal
muscle (Fig. 3). Thus, 
 
cdo
 
 is expressed at low levels in
most adult tissues.
 
Regulation of cdo mRNA by Oncogenes and Serum
 
The PKC3-F4, R-1a, and ER-1-2 cell lines all share the
same original parental cell line, Rat 6. Expression of 
 
cdo
 
mRNA in Rat 6 cells, as well as in Rat 6 cells transformed
by different oncogenes, was therefore assessed. Transfor-
mation of Rat 6 cells by the H-
 
ras
 
, 
 
neu
 
, v-
 
src
 
, v-
 
raf
 
, protein
kinase C 
 
e
 
, or v-fos oncogenes led to a dramatic loss of
expression of cdo (Fig. 4 A). Each of these oncogene-
expressing cell lines was grossly morphologically trans-
formed and formed large colonies in soft agar (Borner et al.,
1992). In contrast, overexpression of protein kinase C b1,
which led to enhanced mitogen-induced signaling but was
a very weak transforming gene (Housey et al., 1988; Borner
et al., 1995), had little effect on cdo expression. Further-
more, hybridization of a rat cdo cDNA probe to Northern
blots of RNA from the murine embryo fibroblast line,
NIH 3T3, revealed an mRNA species that was indistin-
guishable in size from that seen in Rat 6 cells, and this
mRNA was nearly undetectable in NIH 3T3 cells trans-
formed by a K-ras oncogene (Fig. 4 B). Thus, down-regu-
lation of cdo mRNA expression correlated with establish-
ment of the transformed phenotype by several different
oncogenes in Rat 6 cells and by ras oncogenes in two dif-
ferent cell lines.
The possibility that cdo expression might be down-regu-
lated by mitogen treatment was examined next. Fig. 4 C
demonstrates that when confluent, serum-starved Rat 6
cells were stimulated by refeeding with fresh, serum-con-
taining medium, cdo expression was nearly extinguished
within 4 h. Expression began to return within 8–12 h, and
by 24–48 h, it had been restored to the level of the original
cultures. Parallel cultures that were analyzed for cell cycle
progression by flow cytometry indicated that .70% of the
cells were in S phase 16 h after serum stimulation, and that
the cultures were fully quiescent again 24–48 h after-stim-
ulation (data not shown). Thus, steady-state levels of cdo
mRNA were transiently down-regulated as Go-arrested
Figure 3. Expression of cdo in adult rat tissues. PCR-based
“exon-connection” assays for detection of cdo transcripts were
performed as described in the text.
Figure 4. Effect of oncogenes and serum on cdo mRNA expres-
sion. (A) Northern blot analysis of cdo expression in Rat 6 cells
and various oncogene-transformed Rat 6 cell derivatives. The
lane designations refer to the oncogene expressed in the given
Rat 6 cell derivative. The same blot was rehybridized with a rat
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) cDNA
probe as a loading control. (B) Northern blot analysis of cdo ex-
pression in NIH 3T3 cells, and NIH 3T3 cells transformed by the
k-ras oncogene. 1 and 2, expressing or not expressing k-ras, re-
spectively. The ethidium bromide–stained gel, displaying the 28S
and 18S ribosomal RNA bands, is shown as a loading control. (C)
Northern blot analysis of the time course of cdo mRNA expres-
sion in serum-stimulated Rat 6 cells. Confluent cultures of wild-
type Rat 6 cells were serum starved (0 h) and then fed with fresh,
serum-containing medium. Lane designations represent the time,
in hours, after serum stimulation; lane g represents cells growing
logarithmically in serum-containing medium. The ethidium bro-
mide–stained gel, displaying the 28S and 18S ribosomal RNA
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cells reentered the cell cycle and were restored as the cul-
tures regained quiescence. Fig. 4 C also shows that loga-
rithmically growing cells had lower levels of cdo mRNA
than did confluent, serum-starved cells. This appeared not
to be due simply to cell proliferation, per se, or solely to
the fact that these growing cultures were in the presence of
serum, because growth arrest of such cultures by removal
of serum did not significantly increase cdo expression (data
not shown). These data indicate that cell density and/or
cell–cell contact might also play a role in cdo mRNA regu-
lation.
Analysis of CDO Protein in Rat 6 Cells
A complete cdo open reading frame was inserted into the
retroviral expression vector, pBabePuro. This vector was
transiently transfected into the human embryonic kidney
cell line, 293, and Western blot analysis performed on total
cell lysates with polyclonal rabbit antisera raised against
the intracellular region of cdo. A protein of z190 kD was
detected in transfected cells, but not in mock-transfected
controls (Fig. 5 A). An immunoreactive protein with simi-
lar mobility was detected in Rat 6 cell lysates (Fig. 5 A).
A nonspecific, cross-reactive band of lower molecular weight
is also visible in mock-transfected 293 cells and, fre-
quently, in Rat 6 cells. Consistent with the RNA analyses
described above, CDO protein levels were dramatically
down-regulated in ras-transformed Rat 6 cells (C1-T24
cells; Fig. 5 B). Likewise, serum stimulation of quiescent
Rat 6 cultures led to transient down-regulation of CDO
protein levels (Fig. 5 C). It was not possible to perform
similar studies with NIH 3T3 cells, because the antibodies
to CDO appear to be specific for rat.
The amino acid sequence of cdo predicts a transmem-
brane protein. To confirm that CDO was expressed on the
cell surface, various Rat 6 cell derivatives were surface bi-
otinylated. CDO was then immunoprecipitated and de-
tected on Western blots with HRP-coupled streptavidin.
As shown in Fig. 5 D, a band of the appropriate molecular
weight was observed in Rat 6 cells, but was not present in
ras-transformed C1-T24 cells. Furthermore, the signal in-
tensity of the band was increased in Rat 6 cells that over-
produce CDO, and the band was restored in C1-T24 cells
that ectopically produce this protein (see below for a de-
scription of these cell lines). It is concluded that CDO is
expressed on the cell surface.
Members of the IgSF are typically modified in their ex-
tracellular region by N-linked glycosylation (Brummendorf
and Rathjen, 1995). To test whether CDO is also N-glyco-
sylated, Rat 6 cells were treated with tunicamycin, an in-
hibitor of this process. CDO from treated cells displayed a
significant decrease in apparent molecular weight (Fig. 5 E),
consistent with the notion that it is a glycoprotein.
Effect of Cell–Substratum Adhesion on cdo RNA and 
Protein Expression
The expression pattern of cdo in Rat 6 and NIH 3T3 cells
(Fig. 4) suggests that cdo might encode a protein with
growth inhibitory or transformation suppressor function.
Because the primary defect in the R-1a and ER-1-2 mu-
tant cell lines is an inability to proliferate in an anchorage-
independent manner in response to ras (Krauss et al.,
1992; Kang and Krauss, 1996), it was of interest to deter-
mine the effects of cell–substratum adhesion on the ex-
pression of cdo. Rat 6 cells suspended in methylcellulose-
containing medium had significantly lower steady state
levels of cdo mRNA than did parallel adherent cultures. A
similar effect was observed in NIH 3T3 cells (Fig. 6). cdo
mRNA levels were consistently lower in suspension cul-
tures than in adherent cultures of low cell density (data
not shown). It seems likely, however, that the decrease in
steady state cdo mRNA levels seen in the methylcellulose
cultures of Rat 6 cells may reflect a combination of two
phenomena: (a) loss of cell anchorage; and (b) the low cell
density typically used for these suspension cultures, since
decreased cell density in adherent cultures also led to par-
tially reduced levels of cdo mRNA (Fig. 4 C, and see
above).
Although  cdo mRNA levels were down-regulated in non-
adherent Rat 6 cells, some level of expression was always
Figure 5. Western blot analyses of CDO protein expression with
antisera against the CDO intracellular region. (A) Transient trans-
fection of the pBabePuro/cdo vector into 293 cells. 1 and 2, cells
were transfected or mock transfected with the expression vector,
respectively. (B) Ras-mediated down-regulation of CDO protein
levels in Rat 6 cells. C1-T24 cells are a ras-transformed Rat 6 cell
subclone. (C) Serum-mediated down-regulation of CDO protein
levels in Rat 6 cells. Confluent cultures of wild-type Rat 6 cells
were serum starved (0 h) and then fed with fresh, serum-contain-
ing medium. Lane designations represent the time, in hours, after
serum stimulation; note that the times after stimulation at which
CDO protein was analyzed are not identical to those used in anal-
ysis of cdo mRNA in Fig. 2. (D) Cell surface expression of CDO.
Rat 6 and C1-T24 cell derivatives were surface biotinylated and
detected on Western blots with HRP-linked streptavidin. 1 and 2,
cells did, or did not, stably express the pBabePuro/cdo vector. (E)
N-linked glycosylation of CDO. 1 and 2, Rat 6 cells treated or
not treated with tunicamycin, respectively, and then analyzed by
immunoblotting with CDO antisera.Kang et al. CDO: A Novel Member of the Ig/FNIII Family 209
detectable in these cultures. In contrast, CDO protein
could not be detected in suspension cultures (Fig. 6). These
data raised the possibility that CDO protein levels might
be regulated by cell–substratum adhesion by a mechanism
that is independent of cdo mRNA expression. Additional
experiments that address this point are described below.
Ectopic Expression of cdo
To test the hypothesis that cell–substratum adhesion can
regulate CDO protein levels independently of cdo mRNA
expression, we sought to express a cdo cDNA from a pro-
moter whose activity was not influenced by cell culture
conditions. To achieve this, parental Rat 6 cells and a ras-
transformed derivative, C1-T24, were infected with a re-
combinant retrovirus that drives expression of cdo from
the viral long terminal repeat. The cells were infected with
either the cdo-expressing virus or, as a control, a virus that
lacked a cDNA insert. Infectants were then pooled and
the polyclonal populations were analyzed.
Ectopic expression of cdo was assessed by Northern and
Western blot analyses of infected cells cultured under both
adherent and nonadherent conditions. As shown in Fig.
7 A, Rat 6 and C1-T24 cells that were infected with the cdo
virus (Rat 6/cdo and C1-T24/cdo cells, respectively) ex-
pressed abundant, vector-derived mRNA whether they
were attached to plates or suspended in methylcellulose.
When adherent cultures were tested, Rat 6/cdo cells pro-
duced significantly more immunoreactive CDO protein than
control vector-infected cells (Fig. 7 A). C1-T24/cdo cells
also produced large quantities of CDO protein when grown
on tissue culture plates (Fig. 7 A). Control vector-infected
C1-T24 cells expressed no detectable CDO, similar to the
parental C1-T24 cell line shown in Fig. 5 B (see also Fig. 7 B).
Interestingly, no CDO protein was produced when any of
these cell lines was cultured under nonadherent condi-
tions, even though they stably expressed exogenous, vec-
tor-derived cdo mRNA (Fig. 7 A). We have previously
demonstrated that production of several cell cycle proteins
is not altered by culturing these cells in methylcellulose-
containing medium (Kang and Krauss, 1996). Further-
more, immunoblotting of these same cell extracts with an-
tibodies to a different cell surface protein, the insulin-like
growth factor I receptor, did not reveal significant differ-
ences between adherent and nonadherent cultures in the
expression of this protein (data not shown). Loss of CDO
production in nonadherent cultures therefore was not due
to a nonspecific effect, nor was it due to undetected dam-
age to the cells. These data are consistent with the data de-
scribed in Fig. 5, and indicate a requirement, at least in Rat
6 cells, for cell–substratum adhesion for stable production
of CDO protein.
Figure 6. Regulation of cdo mRNA and protein by cell–substra-
tum adhesion in Rat 6 and NIH 3T3 cells. 1 and 2, cells were
cultured on plastic dishes or suspended in methylcellulose-con-
taining medium, respectively. CDO protein and cdo mRNA were
analyzed by Western and Northern blotting techniques, respec-
tively. For the Northern blots, the ethidium bromide–stained gel,
displaying the 28S and 18S ribosomal RNA bands, is shown as a
loading control.
Figure 7. Regulation of ectopic CDO protein production by cell–
substratum adhesion. (A) Rat 6 and C1-T24 cells were infected
with recombinant pBabePuro/cdo virus (1) or pBabePuro virus
lacking a cDNA insert (2), and were cultured on plastic dishes
(1 adhesion) or suspended in methylcellulose-containing me-
dium (2 adhesion). CDO protein expression and mRNA expres-
sion were analyzed by Western and Northern blotting techniques,
respectively. Prolonged exposure of the Northern blot revealed
the endogenous cdo mRNA species in the first two lanes, similar
to the data presented in Fig. 6. (B) C1-T24 cells were infected
with recombinant pBabePuro/cdo virus (1) or pBabePuro virus
lacking a cDNA insert (2), and were then cultured on plastic
dishes at low (L) or high (H) cell density. Also shown are extracts
from tumors derived from C1-T24/puro (2) and C1-T24/cdo (1)
cells. Samples were analyzed for CDO protein expression by
Western blotting techniques. Western blots were also stained
with Ponceau S to confirm that protein samples were not degraded.The Journal of Cell Biology, Volume 138, 1997 210
The failure of Rat 6 cells to produce either endogenous
or ectopically expressed CDO protein in the absence of
cell–substratum adhesion might have arisen, at least in
part, as a result of the low cell density in the methylcellu-
lose cultures used for the nonadherent conditions, rather
than as an absolute need for cell anchorage. To distinguish
between these possibilities, we cultured C1-T24/cdo cells
at low and high cell densities on tissue culture plates and
measured CDO levels by immunoblotting. C1-T24/cdo
cells are most appropriate for addressing this question be-
cause they express only the vector-derived cdo mRNA
which, unlike the endogenous cdo gene, is not regulated
by cell density or cell anchorage. As shown in Fig. 7 B, ad-
herent cultures of C1-T24/cdo cells harvested at low and
high cell densities each produced abundant CDO protein,
indicating that loss of cell substratum adhesion was most
likely to be responsible for the effects observed in Fig. 7 A.
As would be expected of cells that failed to produce the
exogenously derived protein, there was no difference be-
tween C1-T24/cdo cells and control vector-infected C1-
T24 cells in their frequency of colony formation in soft
agar (z20% cloning efficiency). The tumorigenicity of C1-
T24/cdo and control vector-infected C1-T24 cells was also
tested. When 106 cells of each cell line were injected into
the flanks of nude mice, both produced tumors of 1-cm
diam in 10 d. The tumors were then excised, and tested for
expression of CDO protein. Similar to what was observed
with the nonadherent cultures, tumors derived from C1-
T24/cdo cells produced barely detectable levels of CDO
(Fig. 7 B), further indicating a need for engagement of the
cells with an appropriate substratum for stable production
of this protein.
Finally, ectopic expression of CDO protein in adherent
cultures of Rat 6/cdo and C1-T24/cdo cells did not alter
the gross morphology or growth properties of either cell
type when compared with their respective vector control
or parental cell lines (data not shown). Notably, no in-
crease in cell–cell aggregation was observed, as might be ex-
pected for ectopic expression of a cell surface molecule
that mediated homophilic cell adhesion.
It should be noted that the ras-resistant mutant cells also
did not produce CDO protein when cultured in suspension
(data not shown). Thus, the failure of the mutant cell lines
to down-regulate cdo mRNA levels to the same extent ob-
served in transformation-sensitive control cells presum-
ably does not account for their resistance to anchorage-
independent growth. These data do not, however, exclude
a role for CDO as a transformation suppressor in other
systems where stable expression of the protein may occur.
Sequence and Chromosomal Localization of a Human 
Gene Closely Related to cdo
A Southern “zoo” blot containing DNA from various spe-
cies revealed that mouse and human DNA displayed strong
cross-species hybridization to a rat cdo cDNA probe, while
chicken, toad (Xenopus laevis), and zebrafish DNA dis-
played a clearly detectable, but weaker signal (data not
shown). Screening of human fetal brain and fetal lung li-
braries yielded clones that corresponded to a single closely
related gene. These human cDNAs hybridized to an mRNA
species present in several human neuroblastoma cell lines
that was indistinguishable in size from cdo mRNA in Rat 6
cells (data not shown).
The predicted amino acid sequence of this human gene
is shown in comparison to that of rat cdo in Fig. 2 A. The
human and rat genes have identical domain structures in
their extracellular regions, and their intracellular regions,
which do not resemble other known proteins, are also
highly related. Across their full lengths (except for the sig-
nal sequence which was missing from the human cDNA
clones obtained), the two proteins are z81% identical and
z96% similar. The relative positions of amino acids that
define the Ig- and FNIII-like domain consensus sequences
are conserved between the two predicted proteins, as are
all 10 potential N-linked glycosylation sites. Two potential
microexons are apparent in the human sequence: one is a
three–amino acid insertion between Ig-like repeat 5 and
FNIII-like repeat 1; the second is a five–amino acid inser-
tion that is immediately adjacent to the proline-rich se-
quence found in the cytoplasmic tail. Although we cannot
rule out the existence of human genes that are even more
closely related to rat cdo, in this article, this gene will be
referred to as human cdo.
To identify a chromosomal location for human cdo, a
panel of human/rodent monochromosomal hybrids was
screened by PCR with primers that amplify human, but
not rodent, cdo DNA. These studies mapped human cdo
to chromosome 11 (data not shown). PCR analysis of a
chromosome 11 regional mapping panel showed that cdo
mapped to the interval 11q23–24 as defined by the break-
Figure 8. Regional localization of human cdo to chromosome
11q23–24. PCR amplification of human cdo and, as a control, the
catalase locus (CAT; 11p13) in a regional mapping panel contain-
ing the displayed portions of human chromosome 11 in a rodent
cell background. Ethidium bromide–stained gels are shown.
CHO, genomic DNA from CHO cells; Mus, genomic DNA from
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points of the hybrids GM10482 (11q23) and GM11222C
(11q24). Hybrid GM11222C was positive for cdo, whereas
GM10482 was negative (Fig. 8). This region has substan-
tial overlap with similarly sized regions that display LOH
in a high percentage of human breast, ovarian, and lung
cancers (Negrini et al., 1995; Rasio et al., 1995; Gabra et
al., 1996). PCR for the catalase locus (11p13) was used as a
control to confirm the identity of the hybrids (Fig. 8).
Discussion
Proteins of the Ig/FNIII family play important roles in a
variety of developmental and physiological processes. Ad-
ditionally, expression of Ig/FNIII proteins can be highly
dynamic and cell type specific, although little is known of
the signaling pathways that regulate such expression
(Edelman and Crossin, 1991; Brummendorf and Rathjen,
1995; Cunningham, 1995). We report here the molecular
cloning and characterization of rat CDO, a novel cell sur-
face glycoprotein of the Ig/FNIII family. A cdo cDNA was
isolated by screening a genetically dominant, oncogene-
resistant mutant cell line for genes whose expression was
enhanced relative to a transformation-sensitive control
cell line. cdo mRNA and protein were dramatically down-
regulated in rat and mouse embryo fibroblast cell lines
that were transformed by various oncogenes. Addition-
ally,  cdo mRNA and protein levels were strongly, but tran-
siently, reduced when confluent, quiescent cells were stim-
ulated to reenter the cell cycle. These observations raise
the possibility that CDO may serve as a negative regulator
of cell proliferation, transformation, and/or tumorigenesis.
Consistent with this possibility, a human gene that is very
closely related to rat cdo mapped to chromosome 11q23–24,
a region that exhibits LOH in a high percentage of human
breast, ovarian, and lung cancers (Negrini et al., 1995; Ra-
sio et al., 1995; Gabra et al., 1996). cdo therefore joins a
growing list of genes that are not only down-regulated at
the mRNA level in transformed cell lines or tumors, but
may also have transformation suppressor function. Such
genes include those that encode components of the extra-
cellular matrix (fibronectin, collagen); cell surface proteins
(E- and H-cadherin, connexins 26 and 43, certain integrins,
and maspin); and proteins that organize the actin cytoskel-
eton (vinculin, a-actinin, tropomyosin 1) (Plantefaber and
Hynes, 1989; Giancotti and Ruoslahti, 1990; Frixen et al.,
1991; Vleminckx et al., 1991; Fernandez et al., 1992; Gluck
et al., 1993; Prasad et al., 1993; Akamatsu et al., 1996; Hir-
schi et al., 1996; Lee, 1996; Sheng et al., 1996; Travers et al.,
1996).
In addition to regulation of cdo mRNA levels by onco-
genes and serum, CDO protein levels were powerfully
controlled by cell–substratum adhesion, via a mechanism
that was independent of cdo mRNA expression. Rat 6
cells and the Ras-transformed derivative cell line C1-T24
each displayed a cell anchorage requirement for stable
production of CDO, even when this protein was derived
from an ectopically expressed mRNA, whose levels were
not altered by the culture conditions. Preliminary experi-
ments indicate that when suspended C1-T24/cdo cells were
allowed to attach and spread on fibronectin-coated dishes,
CDO was restored to maximal levels 2 h after replating.
Furthermore, attachment-mediated production of CDO
was partially blocked by cytochalasin D (Kang, J.-S., and
R.S. Krauss, unpublished observations). These data sug-
gest a possible role for integrin-mediated signaling and cy-
toskeletal organization in this process. They also raise the
possibility that stable production of CDO may require an
appropriate extracellular matrix microenvironment. Such
a requirement would have important implications for cell
type specificity in the production of CDO and other pro-
teins that might be regulated in a similar fashion. It will be
very interesting to determine whether anchorage or spe-
cific extracellular matrix proteins are required for stable
production of other Ig/FNIII family members. It is not
known whether the loss of CDO protein in suspension cul-
tures occurred at the level of translation or stability. Zhu
et al. (1996) have reported that translation of cyclin D1
mRNA is dependent on cell–substratum adhesion, but un-
like the observations described here for CDO, this effect
of cell anchorage was lost when ectopic cyclin D1 tran-
scripts lacked untranslated regions.
Most CAMs of the IgSF can mediate homophilic binding,
although DCC may be an exception (Fearon, 1996). How-
ever, Rat 6 and C1-T24 cells that ectopically expressed CDO
did not exhibit enhanced cell–cell aggregation. Furthermore,
preliminary studies indicate that a soluble fusion protein
that contains the entire CDO extracellular region is un-
able to bind to Rat 6 or Rat 6/cdo cells, each of which has
abundant CDO on their cell surface (Kang, J.-S., and R.S.
Krauss, unpublished observations). These observations in-
dicate that Rat 6 cells do not express a ligand for CDO on
their cell surface, and also that CDO is probably not a ho-
mophilic CAM. Therefore, it will also be interesting to de-
termine the effects of cell anchorage on CDO production
in a cell system in which a known ligand for CDO is
present. The presence of a ligand could conceivably stabi-
lize or stimulate production of CDO, even in the absence
of optimal cell anchorage. The levels of CDO at the cell
surface may therefore be governed by complex interac-
tions between (a) signals that can regulate cdo gene ex-
pression, such as mitogenic stimuli; and (b) signals that can
regulate CDO protein production, such as appropriate
cell–substratum interactions and, possibly, the presence of
ligands.
Members of the Ig/FNIII repeat family can be organized
into subfamilies by the number of Ig- and FNIII-like re-
peats they contain in their extracellular regions (Brummen-
dorf and Rathjen, 1995; Cunningham, 1995). We are not
aware of any previously reported members of this family
that have the five Ig plus three FNIII combination of re-
peats. CDO’s unique intracellular region also distinguishes
it from other Ig/FNIII proteins. cdo is therefore a founding
member of a new subfamily within the Ig/FNIII repeat
family. Given the structural resemblance of CDO to N-CAM,
DCC, and other Ig/FNIII family members, it is tempting to
speculate that CDO might also play a role in cell migra-
tory events during development of the nervous system
and/or other organ systems. Consistent with this notion,
cdo mRNA is expressed at high levels in several human
neuroblastoma cell lines (Gao, M., and R.S. Krauss, unpub-
lished observations); in addition, preliminary in situ hy-
bridization studies indicate that cdo mRNA is expressed at
high levels in particular regions of the developing rat spi-
nal cord and, interestingly, limb bud (Brose, K., J.-S.The Journal of Cell Biology, Volume 138, 1997 212
Kang, R.S. Krauss, and M. Tessier-Lavigne, unpublished
studies). Because under some conditions Rat 6 cells ex-
press cdo mRNA but not its protein product, it will be im-
portant to identify cell surface production of CDO protein
by particular cell types during development to understand
its function. Understanding CDO’s possible functions in
development and oncogenesis will also require analysis of
the protein’s long cytoplasmic tail, which bears no signifi-
cant resemblance to other known proteins. The dramatic
regulation of cdo mRNA and protein production by mito-
genic and anchorage-related stimuli, combined with CDO’s
unique intracellular region, indicate that further studies of
this protein should yield interesting new insights into cell
proliferation and/or motility, and how such processes may
go awry during tumorigenesis. Such studies are in pro-
gress.
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